Press Release
Stay up to date with the latest developments at Psifas – Israel’s national biobank and personalized medicine platform. This press section features official announcements, research breakthroughs, strategic partnerships, and insights into our genomic and clinical data initiatives. Whether you’re a journalist, researcher,
or industry professional, our updates offer a window into the innovation and impact Psifas is driving in the fields of genomics and health data infrastructure.
We are proud to share a new feature on Illumina’s website highlighting Psifas as a leading Israeli success story in genomic sequencing. In an interview with Prof. Gabriel Barbash, CEO of Psifas, the article describes how the use of NovaSeq X systems enables Psifas to sequence tens of thousands of genomes with high quality, speed, and operational efficiency - supporting a large-scale national clinical-genomic research infrastructure built on longitudinal data.
The Israeli National Initiative for Personalized Medicine, Psifas, and OpenDNA a Genomic AI biotech company have announced a strategic collaboration to develop artificial intelligence models that predict genetic risk for common diseases. The research will combine the power of Psifas’s extensive genomic and clinical data with OpenDNA’s advanced AI technologies.
Lifebit, a global leader in federated Trusted Research Environments (TREs) for genomics and biomedical data, is proud to announce a long-term partnership with Psifas, Israeli Genomic Medicine Initiative. This collaboration will empower groundbreaking advancements in personalised medicine by providing a secure and unified platform for clinical-genomic research across Israel’s diverse population.
We are proud to share a new feature on Illumina’s website highlighting Psifas as a leading Israeli success story in...
The Israeli National Initiative for Personalized Medicine, Psifas, and OpenDNA a Genomic AI biotech company have announced a strategic collaboration...
Lifebit, a global leader in federated Trusted Research Environments (TREs) for genomics and biomedical data, is proud to announce a...